Medinice S.A (WAR:ICE) — Market Cap & Net Worth
Market Cap & Net Worth: Medinice S.A (ICE)
Medinice S.A (WAR:ICE) has a market capitalization of $152.33 Million (zł553.48 Million) as of September 24, 2026. Listed on the WAR stock exchange, this Poland-based company holds position #17689 globally and #119 in its home market, demonstrating a -0.50% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medinice S.A's stock price zł59.60 by its total outstanding shares 9286639 (9.29 Million). Also see Medinice S.A assets under control for a full breakdown of the balance sheet.
Medinice S.A Market Cap History: 2018 to 2026
Medinice S.A's market capitalization history from 2018 to 2026. Data shows growth from $16.36 Million to $152.33 Million (23.81% CAGR). Also see Medinice S.A operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Medinice S.A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Medinice S.A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check ICE stock price and chart for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
106.04x
Medinice S.A's market cap is 106.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.53x
Medinice S.A's market cap is 0.53 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $16.36 Million | $1.11K | -$1.65 Million | 14736.24x | N/A |
| 2019 | $24.28 Million | $164.39K | -$2.25 Million | 147.70x | N/A |
| 2020 | $44.22 Million | $372.00K | -$3.02 Million | 118.86x | N/A |
| 2021 | $52.14 Million | $288.00K | -$2.88 Million | 181.04x | N/A |
| 2022 | $35.63 Million | $246.00K | -$4.92 Million | 144.83x | N/A |
| 2023 | $25.05 Million | $225.00K | -$5.07 Million | 111.32x | N/A |
| 2024 | $19.94 Million | $188.00K | $37.58 Million | 106.04x | 0.53x |
Competitor Companies of ICE by Market Capitalization
Companies near Medinice S.A in the global market cap rankings as of September 24, 2026. Review Medinice S.A (ICE) tangible net worth to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Medinice S.A by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #122 globally with a market cap of $180.30 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #237 globally with a market cap of $105.52 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #122 | Abbott Laboratories | NYSE:ABT | $180.30 Billion | $103.69 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $90.77 |
| #237 | Stryker Corporation | NYSE:SYK | $105.52 Billion | $275.09 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Medinice S.A Historical Marketcap From 2018 to 2026
Between 2018 and today, Medinice S.A's market cap moved from $16.36 Million to $ 152.33 Million, with a yearly change of 23.81%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | zł152.33 Million | +250.59% |
| 2025 | zł43.45 Million | +117.95% |
| 2024 | zł19.94 Million | -20.41% |
| 2023 | zł25.05 Million | -29.70% |
| 2022 | zł35.63 Million | -31.67% |
| 2021 | zł52.14 Million | +17.92% |
| 2020 | zł44.22 Million | +82.11% |
| 2019 | zł24.28 Million | +48.44% |
| 2018 | zł16.36 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 23rd, 2026 the market cap of Medinice S.A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $152.33 Million USD |
| MoneyControl | $152.33 Million USD |
| MarketWatch | $152.33 Million USD |
| marketcap.company | $152.33 Million USD |
| Reuters | $152.33 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Medinice S.A
Medinice S.A., a medical technology company, creates, develops, and commercializes minimally invasive solutions in cardiology and cardiac surgery. The company offers PacePress, a medical device to reduce the risk of complications following the implantation of cardiac electrotherapeutic devices, such as pacemakers or implantable cardioverter-defibrillators; CoolCryo, a cardiac cryoablation technol… Read more